Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3390 results

Sort By:

NT219 Combined With Standard of Care Biologic Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Study ID: NCT06919666
Start Date: 2025-06
End Date: 2031-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

29

Intervention / Treatment

19

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

BC179 Against Alcohol-Induced Damage

Study ID: NCT06899620
Start Date: 2025-05-30
End Date: 2026-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Probiotic group

Placebo group

Sponsor

Wecare Probiotics Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries

Study ID: NCT06723392
Start Date: 2025-06
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1134

Intervention / Treatment

Oral nitrofurantoin monohydrate/macrocrystals

Placebo

Sponsor

NICHD Global Network for Women's and Children's Health

Source: clinicaltrials.gov

Share:
Add to list

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

Study ID: NCT05733689
Start Date: 2025-06
End Date: 2026-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

ctDNA Blood Test

Nice

FOLFOX

FOLFIRI

FOLFIRINOX

PACLITAXEL with or without CARBOPLATIN

DOCETAXEL and IRINOTECAN (alone or combined)

NIVOLUMAB (alone or when added to a regimen above)

PEMBROLIZUMAB (alone or when added to a regimen above)

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients

Study ID: NCT06911489
Start Date: 2025-07
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

116

Intervention / Treatment

68Ga-NRT6020 Injection

177Lu-NRT6020 Injection (stage 2)

177Lu-NRT6020 Injection (stage 3)

Sponsor

Chengdu New Radiomedicine Technology Co. LTD.

Source: clinicaltrials.gov

Share:
Add to list

Development of a Novel Screening Tool for Anosognosia After Stroke.

Study ID: NCT06940882
Start Date: 2025-10
End Date: 2026-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment
Sponsor

University of Exeter

Source: clinicaltrials.gov

Share:
Add to list

Effects of Whole Body Vibration Therapy on Cognitive Function, Balance, and Quality of Life in Older Adults With Mild Cognitive Impairment

Study ID: NCT06927882
Start Date: 2025-06-01
End Date: 2025-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

WBV Therapy Group

Placebo Group:

Control

Sponsor

Jouf University

Source: clinicaltrials.gov

Share:
Add to list

CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

Study ID: NCT06927648
Start Date: 2025-12-31
End Date: 2030-02-28
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

130

Intervention / Treatment
Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Emotion, Aging, and Decision Making

Study ID: NCT06071130
Start Date: 2025-09-03
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

240

Intervention / Treatment

Fit and Strong

Sponsor

DePaul University

Source: clinicaltrials.gov

Share:
Add to list

Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists

Study ID: NCT06839248
Start Date: 2025-05-12
End Date: 2026-02-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

154

Intervention / Treatment

24-hour clear liquid diet

Standard fasting guidelines

Sponsor

St Vincent's Hospital Melbourne

Source: clinicaltrials.gov

Share:
Add to list